|
|
With over 30 years of experience healthcare, academia and biotechnology, Dr. Maria Millan has earned awards and accolades for her career including being named as one of the "Most Influential Women in Bay Area Business" by the San Francisco Business Times in 2022. She spent the past 11 years at the California Institute for Regenerative Medicine (CIRM) and the last 6 years as President and CEO. Dr. Millan led the strategy and financial investments of the agency (capitalized with $8.5B bond funding). Under her leadership, the agency funded hundreds of awards in discovery, translational, therapeutics development, clinical trials, and education awards. She led the team in the creation of the first-in-kind clinical network (Alpha Clinics), translational research infrastructure, and manufacturing network to accelerate the progress of the cell and gene therapy discovery and therapeutics development. Under her leadership as VP of therapeutics development and then as CEO, CIRM’s clinical portfolio grew 5.6-fold to a total of 96 predominantly first-in-human cell and gene therapy clinical trials. CIRM has become a well-known partner and “de-risker” in identifying the most promising scientific progress and supporting the translation of these programs to key proof of principle points where they can gain additional financial support and commercialization path partnerships. CIRM portfolio programs have attracted over $24B in industry partnership and investment to date, the bulk of which occurred while she was President + CEO.
A well-known healthcare leader, Dr. Milan has presented at prominent national and international scientific and industry forums, at think tanks and to leaders of state.
Dr. Millan received her BS from Duke University, her MD from Rutgers with an AOA National Medical Honor Society election and a variety of awards. She trained at Harvard Surgical Services – Beth Israel Deaconess, conducted her post-doctoral research at Harvard’s Sandoz Center for Immunobiology, trained as a pediatric and organ transplant surgeon at Stanford, received multiple research awards and published widely in the field of immunology, transplantation, and cell biology.
She was recruited to Stanford University’s faculty in 1999, was appointed the Director of the Pediatric Organ Transplantation Program within 3 years and was promoted within 5 years from Assistant Professor to Associate Professor. Dr. Millan served on Stanford Medical School’s Faculty Senate, multiple search committees, Hospital Operations and Facility committees and Dean’s advisory committees while at Stanford.
A well-known healthcare leader, Dr. Milan has presented at prominent national and international scientific and industry forums, at think tanks and to leaders of state.
Dr. Millan received her BS from Duke University, her MD from Rutgers with an AOA National Medical Honor Society election and a variety of awards. She trained at Harvard Surgical Services – Beth Israel Deaconess, conducted her post-doctoral research at Harvard’s Sandoz Center for Immunobiology, trained as a pediatric and organ transplant surgeon at Stanford, received multiple research awards and published widely in the field of immunology, transplantation, and cell biology.
She was recruited to Stanford University’s faculty in 1999, was appointed the Director of the Pediatric Organ Transplantation Program within 3 years and was promoted within 5 years from Assistant Professor to Associate Professor. Dr. Millan served on Stanford Medical School’s Faculty Senate, multiple search committees, Hospital Operations and Facility committees and Dean’s advisory committees while at Stanford.
